Advertisement

Droperidol Injection

[01 May 2014]

Products Affected - Description

Droperidol injection, 2.5 mg/mL, American Regent
2 mL vials (NDC 00517-9702-25)
 
Droperidol injection, 2.5 mg/mL, Hospira
2 mL ampule (NDC 00409-1187-01)

Reason for the Shortage

  • American Regent droperidol injection on back order due to manufacturing delays.
  • Hospira has droperidol on back order due to shortage of raw material.

Available Products

No presentations are available.

Estimated Resupply Dates

  • American regent has droperidol 2.5 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
  • Hospira has droperidol 2.5 mg/mL 2 mL ampules on back order and the company cannot estimate a release date.

Related Shortages

Updated

May 1, 2014; February 10, 2014; November 15, 2013; September 18, 2013; July 18, 2013; May 17, 2013; March 25, 2013; March 15, 2013; February 13, 2013; January 9, 2013; December 10, 2012; October 24, 2012; October 5, 2012; August 28, 2012; July 6, 2012; May 17, 2012; April 13, 2012; March 5, 2012; January 3, 2012; November 30, 2011; October 20, 2011; September 30, 2011; September 9, 2011; August 15, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement